Stocks and Investing Stocks and Investing
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017
Wed, September 13, 2017
Tue, September 12, 2017
Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017

Alex Arfaei Initiated (AZN) at Buy and Held Target at $38 on, Sep 7th, 2017


Published on 2024-10-25 22:40:24 -
  Print publication without navigation


Alex Arfaei of BMO Capital, Initiated "AstraZeneca PLC" (AZN) at Buy and Held Target at $38 on, Sep 7th, 2017.

Alex has made no other calls on AZN in the last 4 months.



There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, all agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Seamus Fernandez of "Leerink Swann" Downgraded from Buy to Hold on, Thursday, July 27th, 2017
  • Rebekah Harper of "Credit Suisse" Upgraded from Sell to Hold on, Monday, May 15th, 2017